Found: 37
Select item for more details and to access through your institution.
Proliferation Determined by ki67 Marker and pCR in Locally Advanced Breast Cancer Patients Treated with Neo-adjuvant Chemotherapy.
- Published in:
- Breast Journal, 2013, v. 19, n. 6, p. 685, doi. 10.1111/tbj.12194
- By:
- Publication type:
- Article
Safety and Efficacy of Neo-adjuvant Sequential Dose-Dense Chemotherapy Doublets Combined with Trastuzumab in Patients with HER-2-Positive Early Stage Breast Cancer.
- Published in:
- 2008
- By:
- Publication type:
- Letter
Serum Phospholipids Fatty Acids and Breast Cancer Risk by Pathological Subtype.
- Published in:
- Nutrients, 2020, v. 12, n. 10, p. 3132, doi. 10.3390/nu12103132
- By:
- Publication type:
- Article
Real-world experience with pertuzumab and trastuzumab combined with chemotherapy in neoadjuvant treatment for patients with early-stage HER2-positive breast cancer: the NEOPERSUR study.
- Published in:
- Clinical & Translational Oncology, 2024, v. 26, n. 9, p. 2217, doi. 10.1007/s12094-024-03440-5
- By:
- Publication type:
- Article
The value of sentinel lymph-node biopsy in women with node-positive breast cancer at diagnosis and node-negative tumour after neoadjuvant therapy: a systematic review.
- Published in:
- Clinical & Translational Oncology, 2023, v. 25, n. 2, p. 417, doi. 10.1007/s12094-022-02953-1
- By:
- Publication type:
- Article
The value of sentinel lymph-node biopsy after neoadjuvant therapy: an overview.
- Published in:
- Clinical & Translational Oncology, 2022, v. 24, n. 9, p. 1744, doi. 10.1007/s12094-022-02824-9
- By:
- Publication type:
- Article
TFG-β Nuclear Staining as a Potential Relapse Risk Factor in Early-Stage Non-Small-Cell Lung Cancer.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 22, p. 13780, doi. 10.3390/ijms232213780
- By:
- Publication type:
- Article
Type does matter. Use VIRGIN olive oil as your preferred fat to reduce your risk of breast cancer: case-control EpiGEICAM study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Quality of life with palbociclib plus fulvestrant versus placebo plus fulvestrant in postmenopausal women with endocrine-sensitive hormone receptor-positive and HER2-negative advanced breast cancer: patient-reported outcomes from the FLIPPER trial.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359221148921
- By:
- Publication type:
- Article
Trajectories of alcohol consumption during life and the risk of developing breast cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Pan-European Expert Meeting on the Use of Metronomic Chemotherapy in Advanced Breast Cancer Patients: The PENELOPE Project.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Assessment of Untargeted Metabolomics by Hydrophilic Interaction Liquid Chromatography−Mass Spectrometry to Define Breast Cancer Liquid Biopsy-Based Biomarkers in Plasma Samples.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 10, p. 5098, doi. 10.3390/ijms25105098
- By:
- Publication type:
- Article
SOLTI NeoPARP: a phase II randomized study of two schedules of iniparib plus paclitaxel versus paclitaxel alone as neoadjuvant therapy in patients with triple-negative breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2015, v. 154, n. 2, p. 351, doi. 10.1007/s10549-015-3616-8
- By:
- Publication type:
- Article
Male Breast Cancer: Immunohistochemical Subtypes and Clinical Outcome Characterization.
- Published in:
- Oncology, 2012, v. 83, n. 4, p. 228, doi. 10.1159/000341537
- By:
- Publication type:
- Article
Metabolomics signature as a survival predictor in patients with resectable colorectal liver metastasis.
- Published in:
- Clinical & Translational Medicine, 2024, v. 14, n. 1, p. 1, doi. 10.1002/ctm2.1541
- By:
- Publication type:
- Article
Permutation tests for ASCA in multivariate longitudinal intervention studies.
- Published in:
- Journal of Chemometrics, 2023, v. 37, n. 7, p. 1, doi. 10.1002/cem.3398
- By:
- Publication type:
- Article
Metabolomics unravels subtype-specific characteristics related to neoadjuvant therapy response in breast cancer patients.
- Published in:
- Metabolomics, 2023, v. 19, n. 7, p. 1, doi. 10.1007/s11306-023-02024-8
- By:
- Publication type:
- Article
Predicting dynamic response to neoadjuvant chemotherapy in breast cancer: a novel metabolomics approach.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 14, p. 2658, doi. 10.1002/1878-0261.13216
- By:
- Publication type:
- Article
Olive Oil in Cancer Prevention and Progression.
- Published in:
- Nutrition Reviews, 2006, v. 64, n. 10, p. S40, doi. 10.1301/nr.2006.oct.S40-S52
- By:
- Publication type:
- Article
A Phase II Prospective, Randomized, Double‐Blind, Placebo‐Controlled and Multicenter Clinical Trial to Assess the Safety of 0.005% Estriol Vaginal Gel in Hormone Receptor‐Positive Postmenopausal Women with Early Stage Breast Cancer in Treatment with Aromatase Inhibitor in the Adjuvant Setting
- Published in:
- Oncologist, 2020, v. 25, n. 12, p. 1854, doi. 10.1634/theoncologist.2020-0417
- By:
- Publication type:
- Article
Neoadjuvant Management of Early Breast Cancer: A Clinical and Investigational Position Statement.
- Published in:
- Oncologist, 2019, v. 24, n. 5, p. 603, doi. 10.1634/theoncologist.2018-0228
- By:
- Publication type:
- Article
Neoadjuvant Therapy with Weekly Nanoparticle Albumin-Bound Paclitaxel for Luminal Early Breast Cancer Patients: Results from the NABRAX Study (GEICAM/2011-02), a Multicenter, Non-Randomized, Phase II Trial, with a Companion Biomarker Analysis.
- Published in:
- Oncologist, 2017, v. 22, n. 11, p. 1301, doi. 10.1634/theoncologist.2017-0052
- By:
- Publication type:
- Article
Primary breast cancer and health related quality of life in Spanish women: The EpiGEICAM case-control study.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-63637-w
- By:
- Publication type:
- Article
Challenging Endocrine Sensitivity of Hormone Receptor-Positive/HER2-Negative Advanced Breast Cancer with the Combination of Eribulin and Endocrine Therapy: The REVERT Study.
- Published in:
- Cancers, 2022, v. 14, n. 23, p. 5880, doi. 10.3390/cancers14235880
- By:
- Publication type:
- Article
Hypoxia-Inducible Factor-1 Alpha Expression Is Predictive of Pathological Complete Response in Patients with Breast Cancer Receiving Neoadjuvant Chemotherapy.
- Published in:
- Cancers, 2022, v. 14, n. 21, p. 5393, doi. 10.3390/cancers14215393
- By:
- Publication type:
- Article
Clinical and Sociodemographic Determinants of Adherence to World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) Recommendations in Breast Cancer Survivors—Health-EpiGEICAM Study.
- Published in:
- Cancers, 2022, v. 14, n. 19, p. 4705, doi. 10.3390/cancers14194705
- By:
- Publication type:
- Article
Polymorphisms within Autophagy-Related Genes Influence the Risk of Developing Colorectal Cancer: A Meta-Analysis of Four Large Cohorts.
- Published in:
- Cancers, 2021, v. 13, n. 6, p. 1258, doi. 10.3390/cancers13061258
- By:
- Publication type:
- Article
Human Plasma Metabolomics for Biomarker Discovery: Targeting the Molecular Subtypes in Breast Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 1, p. 147, doi. 10.3390/cancers13010147
- By:
- Publication type:
- Article
Maintenance treatment with Pegylated liposomal doxorubicin versus observation following induction chemotherapy for metastatic breast cancer: GEICAM 2001-01 study.
- Published in:
- Breast Cancer Research & Treatment, 2010, v. 122, n. 1, p. 169, doi. 10.1007/s10549-010-0860-9
- By:
- Publication type:
- Article
Drug Repurposing for Triple-Negative Breast Cancer.
- Published in:
- Journal of Personalized Medicine, 2020, v. 10, n. 4, p. 200, doi. 10.3390/jpm10040200
- By:
- Publication type:
- Article
The role of immunohistochemistry in breast cancer patients treated with neoadjuvant chemotherapy: an old tool with an enduring prognostic value.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
CD133 expression in circulating tumor cells from breast cancer patients: Potential role in resistance to chemotherapy.
- Published in:
- International Journal of Cancer, 2013, v. 133, n. 10, p. 2398, doi. 10.1002/ijc.28263
- By:
- Publication type:
- Article
Classical markers like ER and ki-67, but also survivin and pERK, could be involved in the pathological response to gemcitabine, adriamycin and paclitaxel (GAT) in locally advanced breast cancer patients: results from the GEICAM/2002-01 phase II study.
- Published in:
- Clinical & Translational Oncology, 2012, v. 14, n. 6, p. 430, doi. 10.1007/s12094-012-0820-4
- By:
- Publication type:
- Article
SEOM clinical guidelines for the treatment of early breast cancer.
- Published in:
- Clinical & Translational Oncology, 2010, v. 12, n. 11, p. 711, doi. 10.1007/s12094-010-0584-7
- By:
- Publication type:
- Article
Clinical relevance associated to the analysis of circulating tumour cells in patients with solid tumours.
- Published in:
- Clinical & Translational Oncology, 2009, v. 11, n. 10, p. 659, doi. 10.1007/s12094-009-0421-z
- By:
- Publication type:
- Article
Tumour molecular subtyping according to hormone receptors and HER2 status defines different pathological complete response to neoadjuvant chemotherapy in patients with locally advanced breast cancer.
- Published in:
- Clinical & Translational Oncology, 2008, v. 10, n. 10, p. 646, doi. 10.1007/s12094-008-0265-y
- By:
- Publication type:
- Article
Evaluation of a Gemcitabine-Doxorubicin-Paclitaxel Combination Schedule through Flow Cytometry Assessment of Apoptosis Extent Induced in Human Breast Cancer Cell Lines.
- Published in:
- Cancer Science, 2002, v. 93, n. 5, p. 559, doi. 10.1111/j.1349-7006.2002.tb01291.x
- By:
- Publication type:
- Article